Mallinckrodt NewsLatest News On Mallinckrodt Opioid drug maker Mallinckrodt files for US bankruptcy protection13/10/2020 2:13 am Mallinckrodt files for bankruptcy protection amid US opioid litigation12/10/2020 5:15 pm New York charges Mallinckrodt with insurance fraud over opioid claims22/4/2020 5:30 am New York charges Mallinckrodt with insurance fraud related to opioids22/4/2020 4:06 am Mallinckrodt agrees to US$1.6 bln opioid settlement, unit to seek bankruptcy26/2/2020 5:51 am Mallinckrodt proposes US$1.6 billion opioid deal, Chapter 11 for generics unit: WSJ25/2/2020 3:55 pm Mallinckrodt considering Chapter 11 bankruptcy protection for generics unit: WSJ25/2/2020 7:37 am Mallinckrodt receives SEC subpoena over Acthar gel lawsuit6/11/2019 11:11 am Mallinckrodt taps restructuring firms: report5/9/2019 9:23 am Mallinckrodt expects to pay DoJ US$15.4 million over Questcor investigation6/6/2019 5:04 am Mallinckrodt sues US health agencies, sees 10per cent hit to MS treatment sales22/5/2019 1:40 am Mallinckrodt shares drop after US joins cases over expensive drug1/5/2019 4:11 am FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller12/12/2018 11:34 pm FDA declines to approve reformulated Mallinckrodt opioid12/12/2018 11:18 pm Mallinckrodt plans to spin off specialty generics business6/12/2018 11:06 pm